<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Darunavir</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Darunavir">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Darunavir</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Darunavir</b> (<b>DRV</b>), sold under the brand name <b>Prezista</b> among others, is an antiretroviral medication used to treat and prevent HIV/AIDS.<span class="mw-ref" id="cite_ref-AHFS2016_1-1"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is generally recommended for use with other antiretrovirals.<span class="mw-ref" id="cite_ref-AHFS2016_1-2"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Prezista_FDA_label_3-0"><a href="#cite_note-Prezista_FDA_label-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It is often used with low doses of <a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">ritonavir</a> or cobicistat to increase darunavir levels.<span class="mw-ref" id="cite_ref-AHFS2016_1-3"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It may be used for prevention after a needlestick injury or other potential exposure.<span class="mw-ref" id="cite_ref-AHFS2016_1-4"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is taken by mouth once to twice a day.<span class="mw-ref" id="cite_ref-AHFS2016_1-5"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


<p></p>
<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Darunavir</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Darunavir_structure.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Darunavir_structure.svg.png" data-file-width="512" data-file-height="644" data-file-type="drawing" height="252" width="200"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Darunavir_ball-and-stick_animation.gif" tppabs="https://ptable.com/wiki/compounds/I/m/Darunavir_ball-and-stick_animation.gif" data-file-width="420" data-file-height="284" data-file-type="bitmap" height="135" width="200"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Prezista, Prezcobix, others<span class="mw-ref" id="cite_ref-AHFS2016_1-0"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>TMC114, DRV, darunavir ethanolate</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/darunavir.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/darunavir.html'" tppabs="https://www.drugs.com/monograph/darunavir.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a607042.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a607042.html'" tppabs="https://medlineplus.gov/druginfo/meds/a607042.html" class="external text external">a607042</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Darunavir  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Darunavir'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Darunavir" class="external text external">by INN</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Darunavir  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Darunavir'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Darunavir" class="external text external">Darunavir</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>B2<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_2-0"><a href="#cite_note-Drugs.com_pregnancy-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>N (Not classified yet)<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_2-1"><a href="#cite_note-Drugs.com_pregnancy-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>J05AE10<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=J05AE10  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=J05AE10'" tppabs="https://www.whocc.no/atc_ddd_index/?code=J05AE10" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">CA</abbr></small>:<span> </span> ℞-only<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li>
<li>In<span>&nbsp;</span>general: ℞<span>&nbsp;</span>(Prescription only)</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>37% (without <a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">ritonavir</a>), 82% (with <a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">ritonavir</a>)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>95%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>hepatic (CYP3A4)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>15 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Feces (80%), urine (14%)</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">[(1<i>R</i>,5<i>S</i>,6<i>R</i>)-2,8-dioxabicyclo[3.3.0]oct-6-yl] <i>N</i>-[(2<i>S</i>,3<i>R</i>)-4- [(4-aminophenyl)sulfonyl- (2-methylpropyl)amino]-3-hydroxy-1-phenyl- butan-2-yl] carbamate</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=206361-99-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=206361-99-1'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=206361-99-1" class="external text external">206361-99-1</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/213039  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/213039'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/213039" class="external text external">213039</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01264  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01264'" tppabs="https://www.drugbank.ca/drugs/DB01264" class="external text external">DB01264</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.184733.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.184733.html'" tppabs="http://www.chemspider.com/Chemical-Structure.184733.html" class="external text external">184733</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=YO603Y8113  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=YO603Y8113'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=YO603Y8113" class="external text external">YO603Y8113</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D03656  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D03656'" tppabs="https://www.kegg.jp/entry/D03656" class="external text external">D03656</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:367163  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:367163'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:367163" class="external text external">CHEBI:367163</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1323  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1323'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1323" class="external text external">ChEMBL1323</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">NIAID ChemDB</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=073035  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=073035'" tppabs="https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=073035" class="external text external">073035</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PDB ligand</th><td><div class="plainlist"><ul><li>017 (<span><a href="javascript:if(confirm('https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=017  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=017'" tppabs="https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=017" class="external text external">PDBe</a></span>, <span><a href="javascript:if(confirm('http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=017&polymericType=Any  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=017&polymericType=Any'" tppabs="http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=017&polymericType=Any" class="external text external">RCSB<span>&nbsp;</span>PDB</a></span>)</li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID0046779  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID0046779'" tppabs="https://comptox.epa.gov/dashboard/DTXSID0046779" class="external text external">DTXSID0046779</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.111.730  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.111.730'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.111.730" class="external text external">100.111.730</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>27</sub><span>H</span><sub>37</sub><span>N</span><sub>3</sub><span>O</span><sub>7</sub><span>S</span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">547.67</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DS%28%3DO%29%28c1ccc%28N%29cc1%29N%28CC%28C%29C%29C%5BC%40%40H%5D%28O%29%5BC%40%40H%5D%28NC%28%3DO%29O%5BC%40H%5D2CO%5BC%40H%5D3OCC%5BC%40%40H%5D23%29Cc4ccccc4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DS%28%3DO%29%28c1ccc%28N%29cc1%29N%28CC%28C%29C%29C%5BC%40%40H%5D%28O%29%5BC%40%40H%5D%28NC%28%3DO%29O%5BC%40H%5D2CO%5BC%40H%5D3OCC%5BC%40%40H%5D23%29Cc4ccccc4'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DS%28%3DO%29%28c1ccc%28N%29cc1%29N%28CC%28C%29C%29C%5BC%40%40H%5D%28O%29%5BC%40%40H%5D%28NC%28%3DO%29O%5BC%40H%5D2CO%5BC%40H%5D3OCC%5BC%40%40H%5D23%29Cc4ccccc4" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=S(=O)(c1ccc(N)cc1)N(CC(C)C)C[C@@H](O)[C@@H](NC(=O)O[C@H]2CO[C@H]3OCC[C@@H]23)Cc4ccccc4</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C27H37N3O7S/c1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/t22-,23-,24+,25-,26+/m0/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:CJBJHOAVZSMMDJ-HEXNFIEUSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=460773860&page2=Darunavir  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=460773860&page2=Darunavir'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=460773860&page2=Darunavir" class="external text external">(verify)</a></span></span></td></tr></tbody></table>


<p>Common side effects include diarrhea, nausea, abdominal pain, headache, rash and vomiting.<span class="mw-ref" id="cite_ref-AHFS2016_1-6"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Prezista_FDA_label_3-1"><a href="#cite_note-Prezista_FDA_label-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Severe side effects include allergic reactions, liver problems, and skin rashes such as toxic epidermal necrolysis.<span class="mw-ref" id="cite_ref-AHFS2016_1-7"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> While poorly studied in pregnancy it appears to be safe for the baby.<span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_2-2"><a href="#cite_note-Drugs.com_pregnancy-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It is of the protease inhibitor (PI) class and works by blocking HIV protease.<span class="mw-ref" id="cite_ref-AHFS2016_1-8"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


<p>Darunavir was approved for medical use in the United States in 2006 and in the European Union in February 2007.<span class="mw-ref" id="cite_ref-AHFS2016_1-9"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Prezista_EPAR_4-0"><a href="#cite_note-Prezista_EPAR-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system.<span class="mw-ref" id="cite_ref-WHO21st_5-0"><a href="#cite_note-WHO21st-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span>  The combination darunavir/cobicistat is available as a single pill.<span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>Darunavir is an Office of AIDS Research Advisory Council (DHHS) recommended treatment option for adults and adolescents, regardless of whether they have received HIV treatment in the past.<span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> In a study of patients that had never received HIV treatment, darunavir was as effective as <a href="Lopinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Lopinavir" title="Lopinavir">lopinavir</a>/<a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">ritonavir</a> at 96 weeks with a once-daily dosing.<span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> It was approved by the FDA on 21 October 2008 for people not previously treated for HIV.<span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> As with other antiretrovirals, darunavir does not cure HIV/AIDS.<span class="mw-ref" id="cite_ref-:0_10-0"><a href="#cite_note-:0-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<p>It is indicated for the treatment of human immunodeficiency virus (HIV-1) infection in adults and children three years of age and older when co-administered with ritonavir, in combination with other antiretroviral agents.<span class="mw-ref" id="cite_ref-Prezista_FDA_label_3-2"><a href="#cite_note-Prezista_FDA_label-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Prezista_EPAR_4-1"><a href="#cite_note-Prezista_EPAR-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    
<p>Darunavir is generally well tolerated by people. Rash is the most common side effect (7% of patients).<span class="mw-ref" id="cite_ref-:0_10-1"><a href="#cite_note-:0-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> Other common side effects are diarrhea (2.3%), headache (3.8%), abdominal pain (2.3%), constipation (2.3%), and vomiting (1.5%).<span class="mw-ref" id="cite_ref-:0_10-2"><a href="#cite_note-:0-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> Darunavir can also cause allergic reactions, and people allergic to ritonavir can also have a reaction to darunavir.<span class="mw-ref" id="cite_ref-:0_10-3"><a href="#cite_note-:0-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<p>High blood sugar, diabetes or worsening of diabetes, muscle pain, tenderness or weakness, and increased bleeding in people with hemophilia have been reported in patients taking protease inhibitor medicines like darunavir.<span class="mw-ref" id="cite_ref-:0_10-4"><a href="#cite_note-:0-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> Changes in body fat have been seen in some patients taking medicines for HIV, including loss of fat from legs, arms and face, increased fat in the abdomen and other internal organs, breast enlargement, and fatty lumps on the back of the neck. The cause and long-term health effects of these conditions are not known.<span class="mw-ref" id="cite_ref-:0_10-5"><a href="#cite_note-:0-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Drug_interactions">Drug interactions</h3></summary>
    
<p>Darunavir may interact with medications commonly taken by people with HIV/AIDS such as other antiretrovirals, and antacids such as proton pump inhibitors and H2 receptor antagonists.<span class="mw-ref" id="cite_ref-:0_10-6"><a href="#cite_note-:0-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> St. John's wort may reduce the effectiveness of darunavir by increasing the breakdown of darunavir by the metabolic enzyme <i>CYP3A</i>.<span class="mw-ref" id="cite_ref-:0_10-7"><a href="#cite_note-:0-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanism_of_action">Mechanism of action</h2></summary>
    
<p>Darunavir is a nonpeptidic inhibitor of protease (PR) that lodges itself in the active site of PR through a number of hydrogen bonds.<span class="mw-ref" id="cite_ref-Leonis,_G._2012_11-0"><a href="#cite_note-Leonis,_G._2012-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span>  It was developed to increase interactions with HIV-1 protease and to be more resistant against HIV-1 protease mutations. With a K<sub>d</sub> (dissociation constant) of 4.5 x 10<sup>−12</sup> M, darunavir has a much stronger interaction with PR and its dissociation constant is 1/100 to 1/1000 of other protease inhibitors.<span class="mw-ref" id="cite_ref-King,_N._M._2004_12-0"><a href="#cite_note-King,_N._M._2004-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> This strong interaction comes from increased hydrogen bonds between darunavir and the backbone of the PR active site (Figure 2). Darunavir's structure allows it to create more hydrogen bonds with the PR active site than most PIs that have been developed and approved by the FDA.<span class="mw-ref" id="cite_ref-ReferenceB_13-0"><a href="#cite_note-ReferenceB-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> Furthermore, the backbone of HIV-1 protease maintains its spatial conformation in the presence of mutations.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> Because darunavir interacts with this stable portion of the protease, the PR-PI interaction is less likely to be disrupted by a mutation.<span class="mw-ref" id="cite_ref-ReferenceB_13-1"><a href="#cite_note-ReferenceB-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>

<div class="thumb tleft"><div class="thumbinner" style="width:222px"><img src="../I/m/lossless-page1-220px-Figure_3.a.tiff.png" tppabs="https://ptable.com/wiki/compounds/I/m/lossless-page1-220px-Figure_3.a.tiff.png" data-file-width="822" data-file-height="362" data-file-type="bitmap" height="97" width="220"><div class="thumbcaption" style="text-align: left">Figure 3. Ribbon structure of PR with darunavir in active site: Structures colored as in Fig. 1. with certain residues partaking in hydrogen bonding further highlighted. The catalytic aspartates, 25 and 25’, are in orange and the other interacting residues in green. Right image is a magnified view of the image on the left (PDB 4qdb).</div></div></div>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Catalytic_site">Catalytic site</h3></summary>
    

<p>The chemical activity of the HIV-1 protease depends on two residues in the active site, Asp25 and Asp25’, one from each copy of the homodimer.<span class="mw-ref" id="cite_ref-Zhang,_Y._2014_15-0"><a href="#cite_note-Zhang,_Y._2014-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> Darunavir interacts with these catalytic aspartates and the backbone of the active site through hydrogen bonds, specifically binding to residues Asp25, Asp25’, Asp 29, Asp 30, Asp 30’, and Gly 27 (Figure 3). This interaction prevents viral replication, as it competitively inhibits the viral polypeptides from gaining access to the active site and strongly binds to the enzymatic portions of this protein.<span class="mw-ref" id="cite_ref-Leonis,_G._2012_11-1"><a href="#cite_note-Leonis,_G._2012-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Cost">Cost</h2></summary>
    
<p>In the US and UK, healthcare costs were estimated to be lower with boosted darunavir than with investigator-selected control protease inhibitors in treatment-experienced patients.<span class="mw-ref" id="cite_ref-darunavir_16-0"><a href="#cite_note-darunavir-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/lossless-page1-220px-Figure_2a.tiff.png" tppabs="https://ptable.com/wiki/compounds/I/m/lossless-page1-220px-Figure_2a.tiff.png" data-file-width="402" data-file-height="450" data-file-type="bitmap" height="246" width="220"><div class="thumbcaption" style="text-align: left">Figure 2. Hydrogen bonds between darunavir and HIV-1 protease: The bonds with the red residues indicate hydrogen bonds that are also present between the PI saquinavir and HIV-1 protease. The hydrogen bonds with the blue residue are unique to darunavir.</div></div></div>

<p>Darunavir was approved for use in the United States in June 2006 and for use in the European Union in February 2007.<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-FDA_approval_19-0"><a href="#cite_note-FDA_approval-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-FDA_2011_20-0"><a href="#cite_note-FDA_2011-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-FDA_approval_19-1"><a href="#cite_note-FDA_approval-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-Prezista_EPAR_4-2"><a href="#cite_note-Prezista_EPAR-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<p>The development of first-generation clinical inhibitors was founded on creating more protease-ligand interactions through hydrogen bonding and hydrophobic interactions.<span class="mw-ref" id="cite_ref-Leonis,_G._2012_11-2"><a href="#cite_note-Leonis,_G._2012-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> The first HIV protease inhibitor approved by the FDA was saquinavir, which was designed to target wild-type HIV-1 protease.<span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> However, this inhibitor is no longer effective due to resistance-causing mutations on the HIV-1 protease structure. The HIV genome has high plasticity, so has been able to become resistant to multiple HIV-1 protease inhibitors.<span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> Since saquinavir, the FDA has approved several PIs, including darunavir.<span class="mw-ref" id="cite_ref-FDA_2011_20-1"><a href="#cite_note-FDA_2011-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>
<div style="clear:both;"></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li>Brecanavir</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-AHFS2016-1"> <span id="mw-reference-text-cite_note-AHFS2016-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/darunavir.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/darunavir.html'" tppabs="https://www.drugs.com/monograph/darunavir.html" class="external text external">"Darunavir"</a>. The American Society of Health-System Pharmacists. <a href="javascript:if(confirm('https://web.archive.org/web/20161110112612/https://www.drugs.com/monograph/darunavir.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161110112612/https://www.drugs.com/monograph/darunavir.html'" tppabs="https://web.archive.org/web/20161110112612/https://www.drugs.com/monograph/darunavir.html" class="external text external">Archived</a> from the original on 10 November 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">28 November</span> 2016</span>.</cite></span></li><li id="cite_note-Drugs.com_pregnancy-2"> <span id="mw-reference-text-cite_note-Drugs.com_pregnancy-2" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pregnancy/darunavir.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pregnancy/darunavir.html'" tppabs="https://www.drugs.com/pregnancy/darunavir.html" class="external text external">"Darunavir (Prezista) Use During Pregnancy"</a>. <i>Drugs.com</i>. 23 October 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">21 April</span> 2020</span>.</cite></span></li><li id="cite_note-Prezista_FDA_label-3"> <span id="mw-reference-text-cite_note-Prezista_FDA_label-3" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=814301f9-c990-46a5-b481-2879a521a16f  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=814301f9-c990-46a5-b481-2879a521a16f'" tppabs="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=814301f9-c990-46a5-b481-2879a521a16f" class="external text external">"Prezista- darunavir tablet, film coated Prezista- darunavir suspension"</a>. <i>DailyMed</i>. 6 June 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">21 April</span> 2020</span>.</cite></span></li><li id="cite_note-Prezista_EPAR-4"> <span id="mw-reference-text-cite_note-Prezista_EPAR-4" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ema.europa.eu/en/medicines/human/EPAR/prezista  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ema.europa.eu/en/medicines/human/EPAR/prezista'" tppabs="https://www.ema.europa.eu/en/medicines/human/EPAR/prezista" class="external text external">"Prezista EPAR"</a>. <i>European Medicines Agency (EMA)</i><span class="reference-accessdate">. Retrieved <span class="nowrap">21 April</span> 2020</span>.</cite> <figure-inline><span><img src="../I/m/PD-icon.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/PD-icon.svg.png" data-file-width="196" data-file-height="196" data-file-type="drawing" height="15" width="15"></span></figure-inline><span> </span><i>This article incorporates text from this source, which is in the public domain.</i></span></li><li id="cite_note-WHO21st-5"> <span id="mw-reference-text-cite_note-WHO21st-5" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2019" class="citation book cs1">World Health Organization (2019). <i>World Health Organization model list of essential medicines: 21st list 2019</i>. Geneva: World Health Organization. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/10665%2F325771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F325771'" tppabs="https://hdl.handle.net/10665%2F325771" class="external text external">10665/325771</a></span>. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://aidsinfo.nih.gov/drugs/538/prezcobix/0/patient  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://aidsinfo.nih.gov/drugs/538/prezcobix/0/patient'" tppabs="https://aidsinfo.nih.gov/drugs/538/prezcobix/0/patient" class="external text external">"Darunavir / Cobicistat"</a>. <i>AIDSinfo</i>. U.S. Department of Health and Human Services.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFPanel_on_Antiretroviral_Guidelines_for_Adults_and_Adolescents2019" class="citation journal cs1">Panel on Antiretroviral Guidelines for Adults and Adolescents (18 December 2019). <a href="javascript:if(confirm('https://files.aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://files.aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf'" tppabs="https://files.aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf" class="external text external">"Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV"</a> <span class="cs1-format">(PDF)</span>. Department of Health and Human Services<span class="reference-accessdate">. Retrieved <span class="nowrap">21 April</span> 2020</span>. <a href="javascript:if(confirm('https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/37/whats-new-in-the-guidelines-  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/37/whats-new-in-the-guidelines-'" tppabs="https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/37/whats-new-in-the-guidelines-" class="external text external">Lay summary</a>.</cite><span> </span><span class="cs1-hidden-error error citation-comment">Cite journal requires <code class="cs1-code"><span>|</span>journal=</code> (help)</span></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><a href="javascript:if(confirm('http://www.hivandhepatitis.com/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.hivandhepatitis.com/'" tppabs="http://www.hivandhepatitis.com/" class="external text external">hivandhepatitis.com</a> <a href="javascript:if(confirm('https://web.archive.org/web/20070713123600/http://www.hivandhepatitis.com/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20070713123600/http://www.hivandhepatitis.com/'" tppabs="https://web.archive.org/web/20070713123600/http://www.hivandhepatitis.com/" class="external text external">Archived</a><span> 2007-07-13 at the </span>Wayback Machine, Efficacy  and Safety of Boosted Darunavir (Prezista) Are Superior to Lopinavir/ritonavir  (Kaletra) at 96 Weeks: ARTEMIS Trial, 2008-10-28, <a href="javascript:if(confirm('http://www.hivandhepatitis.com/2008icr/icaac_idsa/docs/102808_e.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.hivandhepatitis.com/2008icr/icaac_idsa/docs/102808_e.html'" tppabs="http://www.hivandhepatitis.com/2008icr/icaac_idsa/docs/102808_e.html" class="external text external">URL</a> <a href="javascript:if(confirm('https://web.archive.org/web/20090719044503/http://www.hivandhepatitis.com/2008icr/icaac_idsa/docs/102808_e.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090719044503/http://www.hivandhepatitis.com/2008icr/icaac_idsa/docs/102808_e.html'" tppabs="https://web.archive.org/web/20090719044503/http://www.hivandhepatitis.com/2008icr/icaac_idsa/docs/102808_e.html" class="external text external">Archived</a><span> 2009-07-19 at the </span>Wayback Machine.</span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><a href="javascript:if(confirm('http://www.hivandhepatitis.com/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.hivandhepatitis.com/'" tppabs="http://www.hivandhepatitis.com/" class="external text external">hivandhepatitis.com</a> <a href="javascript:if(confirm('https://web.archive.org/web/20070713123600/http://www.hivandhepatitis.com/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20070713123600/http://www.hivandhepatitis.com/'" tppabs="https://web.archive.org/web/20070713123600/http://www.hivandhepatitis.com/" class="external text external">Archived</a><span> 2007-07-13 at the </span>Wayback Machine, Darunavir  (Prezista) Receives Full Traditional Approval, Dose Set for Treatment-naive Patients,  Caution Urged for Pregnant Women, 2008-10-24, <a href="javascript:if(confirm('http://www.hivandhepatitis.com/recent/2008/102408_b.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.hivandhepatitis.com/recent/2008/102408_b.html'" tppabs="http://www.hivandhepatitis.com/recent/2008/102408_b.html" class="external text external">URL</a> <a href="javascript:if(confirm('https://web.archive.org/web/20090519004841/http://www.hivandhepatitis.com/recent/2008/102408_b.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090519004841/http://www.hivandhepatitis.com/recent/2008/102408_b.html'" tppabs="https://web.archive.org/web/20090519004841/http://www.hivandhepatitis.com/recent/2008/102408_b.html" class="external text external">Archived</a><span> 2009-05-19 at the </span>Wayback Machine.</span></li><li id="cite_note-:0-10"> <span id="mw-reference-text-cite_note-:0-10" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.prezista.com/patients/full-product-information  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.prezista.com/patients/full-product-information'" tppabs="http://www.prezista.com/patients/full-product-information" class="external text external">"Drug Monograph, Prezista"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20161111061346/http://www.prezista.com/patients/full-product-information  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161111061346/http://www.prezista.com/patients/full-product-information'" tppabs="https://web.archive.org/web/20161111061346/http://www.prezista.com/patients/full-product-information" class="external text external">Archived</a> from the original on 11 November 2016.</cite></span></li><li id="cite_note-Leonis,_G._2012-11"> <span id="mw-reference-text-cite_note-Leonis,_G._2012-11" class="mw-reference-text"><cite id="CITEREFLeonisCzyznikowska2012" class="citation journal cs1">Leonis, G.; Czyznikowska, Z.;  et al. (2012). "Computational Studies of Darunavir into HIV-1 Protease and DMPC Bilayer: Necessary Conditions for Effective Binding and the Role of the Flaps". <i>J. Chem. Inf. Model</i>. <b>52</b>: 1542–1558. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fci300014z  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fci300014z'" tppabs="https://doi.org/10.1021%2Fci300014z" class="external text external">10.1021/ci300014z</a>.</cite></span></li><li id="cite_note-King,_N._M._2004-12"> <span id="mw-reference-text-cite_note-King,_N._M._2004-12" class="mw-reference-text"><cite id="CITEREFKingPrabu-Jeyabalan2004" class="citation journal cs1">King, N. M.; Prabu-Jeyabalan, M.;  et al. (2004). "Structural and Thermodynamic Basis for the Binding of TMC114, a Next-Generation Human Immunodeficiency Virus Type 1 Protease Inhibitor". <i>Journal of Virology</i>. <b>78</b>: 21.</cite></span></li><li id="cite_note-ReferenceB-13"> <span id="mw-reference-text-cite_note-ReferenceB-13" class="mw-reference-text"><cite id="CITEREFLefebvreSchiffer2008" class="citation journal cs1">Lefebvre, E.; Schiffer, C. A. (2008). "Resilience to Resistance of HIV-1 Protease Inhibitors: Profile of Darunavir". <i>AIDS Rev</i>. <b>10</b> (3): 131–142.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite id="CITEREFLascarBenn2009" class="citation journal cs1">Lascar, R. M.; Benn, P. (2009). "Role of darunavir in the management of HIV infection". <i>HIV AIDS (Auckl)</i>. <b>1</b>: 31–39.</cite></span></li><li id="cite_note-Zhang,_Y._2014-15"> <span id="mw-reference-text-cite_note-Zhang,_Y._2014-15" class="mw-reference-text"><cite id="CITEREFLiZhang2014" class="citation journal cs1">Li, D.; Zhang, Y.;  et al. (2014). "Investigation on the mechanism for the binding and drug resistance of wild type and mutations of G86 residue in HIV-1 protease complexed with Darunavir by molecular dynamic simulation and free energy calculation". <i>J. Molecular Modeling</i>. <b>20</b>: 2122. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00894-014-2122-y  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00894-014-2122-y'" tppabs="https://doi.org/10.1007%2Fs00894-014-2122-y" class="external text external">10.1007/s00894-014-2122-y</a>.</cite></span></li><li id="cite_note-darunavir-16"> <span id="mw-reference-text-cite_note-darunavir-16" class="mw-reference-text"><cite id="CITEREFMcKeagePerryKeam2009" class="citation journal cs1">McKeage, K; Perry, CM; Keam, SJ (2009). "Darunavir". <i>Drugs</i>. <b>69</b> (4): 477–503. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-200969040-00007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-200969040-00007'" tppabs="https://doi.org/10.2165%2F00003495-200969040-00007" class="external text external">10.2165/00003495-200969040-00007</a>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite id="CITEREFMacArthur2007" class="citation journal cs1">MacArthur, Rodger D (2007). "Darunavir: promising initial results". <i>The Lancet</i>. <b>369</b>: 1143–1144. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2807%2960499-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2807%2960499-1'" tppabs="https://doi.org/10.1016%2FS0140-6736%2807%2960499-1" class="external text external">10.1016/S0140-6736(07)60499-1</a>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite class="citation pressrelease cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20161113210634/https://www.fda.gov/newsEvents/Newsroom/PressAnnouncements/2006/ucm108676.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161113210634/https://www.fda.gov/newsEvents/Newsroom/PressAnnouncements/2006/ucm108676.htm'" tppabs="https://web.archive.org/web/20161113210634/https://www.fda.gov/newsEvents/Newsroom/PressAnnouncements/2006/ucm108676.htm" class="external text external">"FDA Approves New HIV Treatment for Patients Who Do Not Respond to Existing Drugs"</a>. <i>U.S. Food and Drug Administration (FDA)</i> (Press release). Archived from <a href="javascript:if(confirm('https://www.fda.gov/newsEvents/Newsroom/PressAnnouncements/2006/ucm108676.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/newsEvents/Newsroom/PressAnnouncements/2006/ucm108676.htm'" tppabs="https://www.fda.gov/newsEvents/Newsroom/PressAnnouncements/2006/ucm108676.htm" class="external text external">the original</a> on 13 November 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">10 November</span> 2016</span>.</cite></span></li><li id="cite_note-FDA_approval-19"> <span id="mw-reference-text-cite_note-FDA_approval-19" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021976s000_SprycelTOC.cfm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021976s000_SprycelTOC.cfm'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021976s000_SprycelTOC.cfm" class="external text external">"Drug Approval Package: Prezista (Darumavir) NDA #021976"</a>. <i>U.S. Food and Drug Administration (FDA)</i>. 6 September 2006<span class="reference-accessdate">. Retrieved <span class="nowrap">21 April</span> 2020</span>.</cite></span></li><li id="cite_note-FDA_2011-20"> <span id="mw-reference-text-cite_note-FDA_2011-20" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20190701174234/https://www.fda.gov/patients/hiv-timeline-and-history-approvals/hivaids-historical-time-line-2000-2010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20190701174234/https://www.fda.gov/patients/hiv-timeline-and-history-approvals/hivaids-historical-time-line-2000-2010'" tppabs="https://web.archive.org/web/20190701174234/https://www.fda.gov/patients/hiv-timeline-and-history-approvals/hivaids-historical-time-line-2000-2010" class="external text external">"HIV/AIDS Historical Time Line 2000 - 2010"</a>. <i>U.S. Food and Drug Administration</i>. 5 January 2018. Archived from <a href="javascript:if(confirm('https://www.fda.gov/patients/hiv-timeline-and-history-approvals/hivaids-historical-time-line-2000-2010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/patients/hiv-timeline-and-history-approvals/hivaids-historical-time-line-2000-2010'" tppabs="https://www.fda.gov/patients/hiv-timeline-and-history-approvals/hivaids-historical-time-line-2000-2010" class="external text external">the original</a> on 1 June 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">21 April</span> 2020</span>.</cite></span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite id="CITEREFLiuKovalevsky2008" class="citation journal cs1">Liu, F.; Kovalevsky, A.Y. (2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754059  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754059'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754059" class="external text external">"Effect of Flap Mutations on Structure of HIV-1 Protease and Inhibition by Saquinavir and Darunavir"</a>. <i>J. Mol. Biol</i>. <b>381</b> (1): 102–115. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jmb.2008.05.062  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jmb.2008.05.062'" tppabs="https://doi.org/10.1016%2Fj.jmb.2008.05.062" class="external text external">10.1016/j.jmb.2008.05.062</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754059  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754059'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754059" class="external text external">2754059</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18597780  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18597780'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18597780" class="external text external">18597780</a>.</cite></span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text"><cite id="CITEREFEron2000" class="citation journal cs1">Eron, J (2000). "HIV-1 Protease Inhibitors". <i>Oxford Journal of Clinical Infectious Diseases</i>. <b>30</b>: 160–170.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Further_reading">Further reading</h2></summary>
    
<ul><li><cite class="citation journal cs1">Panel on Antiretroviral Guidelines for Adults and Adolescents (18 December 2019). <a href="javascript:if(confirm('https://files.aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://files.aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf'" tppabs="https://files.aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf" class="external text external">"Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV"</a> <span class="cs1-format">(PDF)</span>. Department of Health and Human Services. <a href="javascript:if(confirm('https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/37/whats-new-in-the-guidelines-  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/37/whats-new-in-the-guidelines-'" tppabs="https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/37/whats-new-in-the-guidelines-" class="external text external">Lay summary</a>.</cite><span> </span><span class="cs1-hidden-error error citation-comment">Cite journal requires <code class="cs1-code"><span>|</span>journal=</code> (help)</span></li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/darunavir  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/darunavir'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/darunavir" class="external text external">"Darunavir"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Antiviral_drugs:_antiretroviral_drugs_used_against_HIV_(primarily_J05)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antiviral_drugs:_antiretroviral_drugs_used_against_HIV_(primarily_J05)" style="font-size:114%;margin:0 4em">Antiviral drugs: antiretroviral drugs used against HIV (primarily J05)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Entry/fusion inhibitors <br> <i>(Discovery and development)</i></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>gp41</i> (<a href="Enfuvirtide.htm" tppabs="https://ptable.com/wiki/compounds/A/Enfuvirtide" title="Enfuvirtide">Enfuvirtide (ENF, T-20)</a>)</li>
<li><i>CCR5</i> (<a href="Maraviroc.htm" tppabs="https://ptable.com/wiki/compounds/A/Maraviroc" title="Maraviroc">Maraviroc (MVC)</a></li>
<li>Vicriviroc<sup>†</sup>, Cenicriviroc<sup>†</sup>, PRO 140<sup>†</sup>)</li>
<li><i>CD4</i> (Ibalizumab<sup>†</sup>, UB421<sup>§</sup>)</li>
<li><i>gp120</i> (Fostemsavir)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Reverse-transcriptase<br> inhibitors (RTIs)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Nucleoside and<br> nucleotide (NRTI)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Nucleoside analogues/NRTIs:</i>  <a href="Abacavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Abacavir" title="Abacavir">Abacavir (ABC)</a>°<sup>#</sup></li>
<li><a href="Didanosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Didanosine" title="Didanosine">Didanosine (ddI)</a></li>
<li><a href="Emtricitabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Emtricitabine" title="Emtricitabine">Emtricitabine (FTC)</a>°</li>
<li><a href="Lamivudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lamivudine" title="Lamivudine">Lamivudine (3TC)</a>°<sup>#</sup></li>
<li><a href="Stavudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Stavudine" title="Stavudine">Stavudine (d4T)</a><sup>#</sup></li>
<li><a href="Zidovudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Zidovudine" title="Zidovudine">Zidovudine (AZT, ZDV)</a><sup>#</sup></li>
<li>Amdoxovir<sup>†</sup></li>
<li>Apricitabine<sup>†</sup></li>
<li>Censavudine<sup>†</sup></li>
<li>Elvucitabine<sup>†</sup></li>
<li>Islatravir (EFdA)<sup>§</sup></li>
<li>Racivir<sup>†</sup></li>
<li>Stampidine<sup>†</sup></li>
<li><a href="Zalcitabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Zalcitabine" title="Zalcitabine">Zalcitabine (ddC)</a><sup>◊</sup></li></ul>

<ul><li><i>Nucleotide analogues/NtRTIs:</i>  Tenofovir disoproxil (TDF)°<sup>#</sup></li>
<li>Tenofovir alafenamide (TAF)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Non-nucleoside (NNRTI)<br><i>(Discovery and development)</i></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">1<sup>st</sup> generation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz (EFV)</a>°<sup>#</sup></li>
<li><a href="Nevirapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nevirapine" title="Nevirapine">Nevirapine (NVP)</a><sup>#</sup></li>
<li><a href="Delavirdine.htm" tppabs="https://ptable.com/wiki/compounds/A/Delavirdine" title="Delavirdine">Delavirdine (DLV)</a><sup>◊</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">2<sup>nd</sup> generation</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>diarylpyrimidines</i>
<ul><li>Etravirine (ETR)</li>
<li>Rilpivirine (RPV)°</li></ul></li>
<li>Doravirine°</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Integrase inhibitors<br>(Integrase strand transfer inhibitors (INSTI))</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Dolutegravir (DTG)°</li>
<li>Elvitegravir (EVG)°</li>
<li>Raltegravir (RAL)°</li>
<li>BI 224436<sup>†</sup></li>
<li>Cabotegravir<sup>†</sup></li>
<li>Bictegravir (BIC)<sup>†</sup></li>
<li>MK-2048<sup>†</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Maturation inhibitors</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bevirimat<sup>†</sup></li>
<li>BMS-955176<sup>§</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Protease Inhibitors (PI)<br><i>(Discovery and development)</i></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">1<sup>st</sup> generation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amprenavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Amprenavir" title="Amprenavir">Amprenavir (APV)</a><sup>◊</sup></li>
<li><a href="Fosamprenavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosamprenavir" title="Fosamprenavir">Fosamprenavir (FPV)</a></li>
<li><a href="Indinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Indinavir" title="Indinavir">Indinavir (IDV)</a><sup>◊</sup></li>
<li><a href="Lopinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Lopinavir" title="Lopinavir">Lopinavir (LPV)</a></li>
<li><a href="Nelfinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Nelfinavir" title="Nelfinavir">Nelfinavir (NFV)</a></li>
<li><a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">Ritonavir (RTV)</a><sup>#</sup></li>
<li><a href="Saquinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Saquinavir" title="Saquinavir">Saquinavir (SQV)</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">2<sup>nd</sup> generation</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Atazanavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Atazanavir" title="Atazanavir">Atazanavir (ATV)</a>°<sup>#</sup></li>
<li><a href="Darunavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Darunavir" title="Darunavir">Darunavir (DRV)</a>°<sup>#</sup></li>
<li><a href="Tipranavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Tipranavir" title="Tipranavir">Tipranavir (TPV)</a></li>
<li>TMC-310911<sup>§</sup></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Combined formulations</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Abacavir/lamivudine°<sup>#</sup></li>
<li>Abacavir/dolutegravir/lamivudine°</li>
<li>Abacavir/lamivudine/zidovudine</li>
<li>Atazanavir/cobicistat</li>
<li>Bictegravir/emtricitabine/tenofovir alafenamide</li>
<li>Darunavir/cobicistat</li>
<li>Darunavir/cobicistat/emtricitabine/tenofovir alafenamide</li>
<li>Dolutegravir/lamivudine</li>
<li>Dolutegravir/lamivudine/tenofovir</li>
<li>Dolutegravir/rilpivirine</li>
<li>Doravirine/lamivudine/tenofovir</li>
<li>Efavirenz/emtricitabine/tenofovir°<sup>#</sup></li>
<li>Efavirenz/lamivudine/tenofovir<sup>#</sup></li>
<li>Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide</li>
<li>Elvitegravir/cobicistat/emtricitabine/tenofovir°</li>
<li>Emtricitabine/tenofovir alafenamide</li>
<li>Emtricitabine/rilpivirine/tenofovir alafenamide</li>
<li>Emtricitabine/rilpivirine/tenofovir°</li>
<li>Emtricitabine/tenofovir°<sup>#</sup></li>
<li>Lamivudine/nevirapine/stavudine<sup>#</sup></li>
<li>Lamivudine/nevirapine/zidovudine<sup>#</sup></li>
<li>Lamivudine/raltegravir</li>
<li>Lamivudine/tenofovir</li>
<li>Lamivudine/zidovudine<sup>#</sup></li>
<li>Lopinavir/ritonavir°<sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Pharmacokinetic boosters</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cobicistat (c)</li>
<li><a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">Ritonavir (r)</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Experimental agents</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Uncoating inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>TRIM5alpha (gene)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Transcription inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Tat antagonists</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Translation inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Trichosanthin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"> BNAbs</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Elipovimab</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Abzyme</li>
<li>BIT225<sup>†</sup></li>
<li>Calanolide A</li>
<li>Ceragenin</li>
<li>Cyanovirin-N</li>
<li>Diarylpyrimidines</li>
<li><a href="Epigallocatechin_gallate.htm" tppabs="https://ptable.com/wiki/compounds/A/Epigallocatechin_gallate" title="Epigallocatechin gallate">Epigallocatechin gallate (EGCG)</a></li>
<li><a href="Foscarnet.htm" tppabs="https://ptable.com/wiki/compounds/A/Foscarnet" title="Foscarnet">Foscarnet</a></li>
<li>Fosdevirine<sup>†</sup></li>
<li>Griffithsin</li>
<li><a href="Hydroxycarbamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxycarbamide" title="Hydroxycarbamide">Hydroxycarbamide</a></li>
<li>KP-1461<sup>†</sup></li>
<li><a href="Miltefosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Miltefosine" title="Miltefosine">Miltefosine</a></li>
<li>Portmanteau inhibitors</li>
<li>Scytovirin</li>
<li>Seliciclib<sup>†</sup></li>
<li>Synergistic enhancers</li>
<li>Tre recombinase</li>
<li>Zinc finger protein transcription factor</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Failed agents</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Aplaviroc</li>
<li>Atevirdine</li>
<li>Brecanavir</li>
<li>Capravirine</li>
<li>Dexelvucitabine</li>
<li>Droxinavir</li>
<li>Lasinavir</li>
<li>Emivirine</li>
<li>Lersivirine</li>
<li>Lodenosine</li>
<li>Loviride</li>
<li>Mozenavir</li>
<li><span class="new">Palinavir</span></li>
<li><span class="new">Telinavir</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div> °DHHS <i>recommended</i> initial regimen options. <sup>◊</sup>Formerly or rarely used agent.<br></div></td></tr></tbody></table></div>









<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-07-30" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Darunavir&oldid=970235239  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Darunavir&oldid=970235239'" tppabs="https://en.wikipedia.org/wiki/?title=Darunavir&oldid=970235239">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>